HVTN704/HPTN 085 Protocol Funding

Dates: 10/1/2015 - 11/30/2020

Fred Hutch/NIH

Role: LaRon Earnest Nelson, PhD, RN, FNP, FNAP, FAAN : Protocol Team Member and University of Rochester Site PI
Principal Investigator:

To evaluate the safety and tolerability of VRC01 broadly neutralizing monoclonal antibodies (bnAb) administered through IV infusion in each of 2 cohorts and to determine if the VRC01 bnAb prevents HIV-1 infection and to estimate the level of efficacy in each of 2 cohorts.